ALX Oncology (ALXO) Stock Forecast & Price Target

$0.54 -0.06 (-9.87%)

Closing price 04/25/2025 04:00 PM Eastern

Extended Trading

$0.55 +0.01 (+1.35%)

As of 04/25/2025 07:37 PM Eastern

ALX Oncology - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 7 Analyst Ratings

Sell
0

Hold
2

Buy
5

Based on 7 Wall Street analysts who have issued ratings for ALX Oncology in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 2 have given a hold rating, and 5 have given a buy rating for ALXO.

Consensus Price Target

$4.14
664.26% Upside

According to the 7 analysts' twelve-month price targets for ALX Oncology, the average price target is $4.14. The highest price target for ALXO is $9.00, while the lowest price target for ALXO is $1.50. The average price target represents a forecasted upside of 664.26% from the current price of $0.54.

Get the Latest News and Ratings for ALXO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for ALX Oncology and its competitors.

ALXO Analyst Ratings Over Time

Type	Current Forecast 4/26/24 to 4/26/25	1 Month Ago 3/27/24 to 3/27/25	3 Months Ago 1/27/24 to 1/26/25	1 Year Ago 4/27/23 to 4/26/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	3 Buy rating(s)	6 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$4.14	$4.14	$3.50	$18.83
Forecasted Upside	664.26% Upside	479.67% Upside	131.02% Upside	11.70% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ALXO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALXO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ALX Oncology Stock vs. The Competition

Type	ALX Oncology	Medical Companies	S&P 500
Consensus Rating Score	2.71	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	664.26% Upside	2,772.56% Upside	21.41% Upside
News Sentiment Rating	Neutral News See Recent ALXO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/7/2025	Stifel Nicolaus 4 of 5 stars	Bradley Canino Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$3.00 ➝ $1.50	+39.53%
3/7/2025	HC Wainwright 1 of 5 stars	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00 ➝ $5.00	+281.68%
3/6/2025	Piper Sandler 2 of 5 stars	Christopher Raymond Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$8.00 ➝ $9.00	+628.74%
3/6/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$2.00 ➝ $3.00	+188.46%
1/27/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Colin Bristow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$4.00 ➝ $2.20	+50.17%
1/24/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Li Watsek Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
7/31/2024	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slutsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:08 AM ET.

ALXO Forecast - Frequently Asked Questions

: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for ALX Oncology is $4.14, with a high forecast of $9.00 and a low forecast of $1.50.
: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ALX Oncology in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALXO shares.
: According to analysts, ALX Oncology's stock has a predicted upside of 664.26% based on their 12-month stock forecasts.
: Over the previous 90 days, ALX Oncology's stock had 1 upgrade by analysts.
: ALX Oncology has been rated by research analysts at HC Wainwright, Jefferies Financial Group, Piper Sandler, Stifel Nicolaus, and UBS Group in the past 90 days.
: Analysts like ALX Oncology less than other "medical" companies. The consensus rating score for ALX Oncology is 2.71 while the average consensus rating score for "medical" companies is 2.82. Learn more on how ALXO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:ALXO) was last updated on 4/26/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ALX Oncology (ALXO) Stock Forecast & Price Target